Helus Pharma Inc. SEC filings HELP
Helus Pharma Inc. has 452 filings in SEC EDGAR's recent list, going back to Nov 20, 2020. Its latest annual report, Form 40-F, was filed on Jun 29, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 3 | Initial insider ownership | Nov 2, 2026 | Oct 16, 2026 |
| 3 | Initial insider ownership | Oct 26, 2026 | Oct 13, 2026 |
| 3 | Initial insider ownership | Oct 26, 2026 | Oct 13, 2026 |
| 3 | Initial insider ownership | Oct 23, 2026 | Oct 13, 2026 |
| 3 | Initial insider ownership | Oct 23, 2026 | Oct 13, 2026 |
| 3 | Initial insider ownership | Oct 23, 2026 | Oct 13, 2026 |
| 3 | Initial insider ownership | Oct 23, 2026 | Oct 13, 2026 |
| 4 | Insider transaction | Oct 1, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Oct 1, 2026 | Sep 29, 2026 |
| 3 | Initial insider ownership | Oct 1, 2026 | Sep 29, 2026 |
| 4 | Insider transaction | Oct 1, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Sep 21, 2026 | Sep 21, 2026 |
| 3 | Initial insider ownership | Sep 17, 2026 | Sep 17, 2026 |
| 4 | Insider transaction | Sep 11, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 11, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 11, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 10, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 10, 2026 | Sep 3, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | Sep 9, 2026 | — |
| 4 | Insider transaction | Sep 9, 2026 | Sep 1, 2026 |
| 3 | Initial insider ownership | Sep 9, 2026 | Sep 1, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | Sep 9, 2026 | — |
| 4 | Insider transaction | Sep 9, 2026 | Aug 31, 2026 |
| 3 | Initial insider ownership | Sep 9, 2026 | Aug 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 12, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 22, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 10, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 26, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 7, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 4, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 29, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 21, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SC 13G | Ownership over 5% (passive) | Dec 3, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Aug 27, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Mar 25, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Mar 22, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 17, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Nov 7, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Sep 15, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 11, 2022 | — |
Showing 55 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HELP (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Toronto
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1833141
- Former names
- CYBIN INC. (until Sep 23, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.